Multicenter, placebo‐controlled, double‐blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy‐induced nausea and vomiting in patients receiving highly emetogenic chemotherapy

Shunichi Sugawara, Tomohide Tamura, Masashi Kanehara et al.|Cancer|2019

Cited by 16